BEVERLY, Mass. – seqWell, a global provider of genomic library workflow solutions including the plexWell™ next-generation sequencing (NGS) multiplexing technology, today announced the appointment of Dr Amy Liao to its Board. Amy joins the current Board of Directors, led by Chairman Paul McEwan. The appointment supports the commercial development of the Company’s existing and future products, following its recent $7M Series […]
Tapestri Center of Excellence program expands globally to offer Tapestri’s single-cell multi-omics capabilities across Europe SOUTH SAN FRANCISCO, Calif. and BARCELONA, Spain — Mission Bio, Inc., the pioneer in high-throughput single-cell DNA and multi-omics analysis, today announced a new Center of Excellence, located at the Josep Carreras Leukaemia Research Institute and led by Manel Esteller, MD, PhD. […]
SAN FRANCISCO — Syapse®, a leading real-world evidence company announced with Pierian®, a global leader in advanced clinical genomics technology, a new joint collaboration that will benefit patients of the AdventHealth Cancer Institute in Central Florida. The collaboration combines Syapse’s real-world evidence solutions designed to improve outcomes for patients with cancer, Pierian’s leading-edge clinical genomics workflow, and […]
Genomics Veteran to Lead Company Which Has a Commercial-Ready Novel Technology Platform that Can Realize the Largely Untapped Contribution of Epigenetics to Human Health CAMBRIDGE, United Kingdom — Cambridge Epigenetix (CEGX), a life sciences tools and technology company which is revolutionizing genome sequencing, today announced the appointment of Peter J. Fromen as Chief Executive Officer […]
Emeryville, CA (June 14, 2022) – SLINGSHOT BIOSCIENCES, INC. the makers of synthetic cells that bring consistent precision and accurate control to replace inconsistent blood and tissue controls for use in flow cytometry and other biotech markets, today announced they have extended their distribution channel through a new agreement with Ozyme, a French company dedicated […]
BOSTON, United States and LAUSANNE, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a leader in data-driven medicine, today announced from the ESHG Conference in Vienna that it has achieved CE-IVD certification for the analytical functionality supported by its cloud-based SOPHiA DDM™ Platform, an accessory to diagnostic applications. With this certification, the SOPHiA DDM™ Platform is now IVD-ready […]
BeginNGS™ to accelerate newborn screening by rapid whole genome sequencing to help diagnose and treat genetic diseases with available therapies SAN DIEGO — Rady Children’s Institute for Genomic Medicine (RCIGM®) today announced a novel program to advance and evaluate scalability of a diagnostic and precision medicine guidance tool called BeginNGS™ (pronounced “beginnings”) to screen newborns for approximately 400 genetic diseases […]
San Diego, California — Dr. Kiana Aran, Associate Professor of Medical Diagnostics and Therapeutics at Keck Graduate Institute (KGI) and Chief Scientific Officer of Cardea Bio, recently received a Research Gift from Agilent Technologies‘ university relations program to support her research on developing a scalable detection platform to continuously monitor the quality and health of cell cultures using […]
UPPSALA, Sweden — Olink Holding AB (publ) (Nasdaq: OLK) today announced that FinnGen in Finland will use Olink technology to provide detailed proteomics data to improve understanding of human health. FinnGen, is a large-scale academic/industrial research collaboration in Finland with the scope to collect and analyze genomic and health data from 500,000 Finnish biobank participants. It […]
Dublin, Ireland: ERS Genomics Limited (‘ERS’) is pleased to report that India Patent No. 397884 was granted on May 27, 2022. This patent covers methods and compositions for use of CRISPR/Cas9 and chimeric Cas9 in all cell types including eukaryotic cells. ERS, co-founded by Dr. Emmanuelle Charpentier, 2020 Nobel Prize winner for gene-editing, provides access to this foundational CRISPR/Cas9 […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
